ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Large-Scale Quantitative Morphometry of Platelet α-Granules via SIM Super-Resolution Microscopy for Cancer Liquid Biopsy.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
29 authors.
Funding
Abstract
Blood-based liquid biopsies hold transformative potential for non-invasive cancer management, but current approaches relying on rare circulating tumor components limit their broad clinical utility. Platelets, abundant in blood and mediating diverse cancer-associated responses, represent a compelling yet largely unexplored alternative. Using SIM super-resolution microscopy, we analyzed α-granule distributions in platelets from a multicenter cohort (n = 1,556) encompassing nine cancer types and twelve non-malignant diseases. We identified robust cancer-associated alterations, particularly a marked increase in the "Circle" pattern, which exhibits excellent multi-cancer diagnostic potential. This method, termed PAID (Platelet Alpha-granule Imaging-based Diagnostic assay), achieved 85.0% accuracy in prostate cancer within the diagnostically challenging PSA "gray zone". PAID combined with PSA improved diagnostic accuracy to 94.2%, 38.4% over PSA alone, suggesting significant synergy. In ovarian cancer, PAID combined with HE4 enhanced diagnostic accuracy from 73.8% to 88.3%. Furthermore, PAID outperformed CA125 in sensitivity (90.3% vs 60.0%) for detecting ovarian cancer recurrence. We also observed that tumor cells may utilize both tumor-derived exosomes and proteins to remodel platelet α-granule distributions, suggesting the increased "Circle" pattern arises from synergistic rather than singular triggers. The non-invasive, highly accurate PAID shows great promise in advancing liquid biopsy for cancer management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.